MENA Vaccine Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
                     MENA Vaccine Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A c c o r d i n g  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  G r o u p ,  t i t l e d  " M E N A  V a c c i n e  M a r k e t :  I n d u s t r y  
T r e n d s ,  S h a r e ,  S i z e ,  G r o w t h ,  O p p o r t u n i t y  a n d  F o r e c a s t  2 0 2 4 - 2 0 3 2 , "  t h e  M E N A  v a c c i n e  
m a r k e t  s i z e  i s  p r o j e c t e d  t o  e x h i b i t  a  g r o w t h  r a t e  ( C A G R )  o f  3 . 4 %  d u r i n g  2 0 2 4 - 2 0 3 2 .
A  v a c c i n e  i s  a  b i o l o g i c a l  p r e p a r a t i o n  t h a t  p r o v i d e s  a c t i v e  a c q u i r e d  i m m u n i t y  t o  a  p a r t i c u l a r  
i n f e c t i o u s  d i s e a s e .  I t  t y p i c a l l y  c o n t a i n s  a n  a g e n t  t h a t  r e s e m b l e s  a  d i s e a s e - c a u s i n g  
Report m i c r o o r g a n i s m  a n d  i s  o f t e n  m a d e  f r o m  w e a k e n e d  o r  k i l l e d  f o r m s  o f  t h e  m i c r o b e ,  i t s  t o x i n s ,  o r  o n e  o f  i t s  s u r f a c e  p r o t e i n s .  T h e  a g e n t  s t i m u l a t e s  t h e  b o d y ' s  i m m u n e  s y s t e m  t o  r e c o g n i z e  t h e  
a g e n t  a s  a  t h r e a t ,  d e s t r o y  i t ,  a n d  r e m e m b e r  i t ,  s o  t h a t  t h e  i m m u n e  s y s t e m  c a n  m o r e  e a s i l y  
Highlight and r e c o g n i z e  a n d  d e s t r o y  a n y  o f  t h e s e  m i c r o o r g a n i s m s  t h a t  i t  l a t e r  e n c o u n t e r s .  V a c c i n e s  a r e  a  f u n d a m e n t a l  c o m p o n e n t  o f  m o d e r n  m e d i c i n e  a n d  p u b l i c  h e a l t h ,  p r e v e n t i n g  t h e  s p r e a d  o f  
i n f e c t i o u s  d i s e a s e s  t h a t  w e r e  o n c e  w i d e s p r e a d  a n d  l e t h a l ,  s u c h  a s  p o l i o ,  m e a s l e s ,  a n d  
Description s m a l l p o x .  O v e r  t i m e ,  v a c c i n a t i o n  h a s  b e e n  e x p a n d e d  t o  p r e v e n t  a  w i d e  v a r i e t y  o f  d i s e a s e s ,  e n s u r i n g  b e t t e r  h e a l t h  a n d  s a f e t y  o f  p o p u l a t i o n s .  T h e  d e v e l o p m e n t  a n d  a d m i n i s t r a t i o n  o f  
v a c c i n e s  i n v o l v e  r i g o r o u s  t e s t i n g  f o r  s a f e t y  a n d  e f f i c a c y ,  a n d  t h e y  a r e  a m o n g  t h e  m o s t  c o s t -
e f f e c t i v e  h e a l t h  i n t e r v e n t i o n s  a v a i l a b l e .  B y  t r a i n i n g  t h e  i m m u n e  s y s t e m  t o  f i g h t  p a t h o g e n s ,  
v a c c i n e s  n o t  o n l y  p r o t e c t  i n d i v i d u a l s  b u t  a l s o  c o n t r i b u t e  t o  " h e r d  i m m u n i t y , "  d e c r e a s i n g  t h e  
c h a n c e  o f  o u t b r e a k s .
R e q u e s t  f o r  a  P D F  s a m p l e  o f  t h i s  r e p o r t :  
h t t p s : / / w w w . i m a r c g r o u p . c o m / m e n a - v a c c i n e - m a r k e t / r e q u e s t s a m p l e
Report Description
M E N A  V a c c i n e  M a r k e t  T r e n d s :
T h e  v a c c i n e  m a r k e t  i n  t h e  M E N A  r e g i o n  i s  e x p e r i e n c i n g  s i g n i f i c a n t  g r o w t h  d r i v e n  b y  t h e  i n c r e a s i n g  p r e v a l e n c e  o f  i n f e c t i o u s  d i s e a s e s  a n d  t h e  
o n g o i n g  n e e d  t o  c o n t r o l  p u b l i c  h e a l t h  t h r e a t s  f u e l  t h e  d e m a n d  f o r  e f f e c t i v e  v a c c i n a t i o n  p r o g r a m s .  D i s e a s e s  s u c h  a s  h e p a t i t i s ,  t u b e r c u l o s i s ,  a n d  
i n f l u e n z a  r e m a i n  p r e v a l e n t  i n  s e v e r a l  M E N A  c o u n t r i e s ,  p u s h i n g  g o v e r n m e n t s  a n d  h e a l t h c a r e  p r o v i d e r s  t o  i m p r o v e  v a c c i n a t i o n  c o v e r a g e .  
B e s i d e s ,  r i s i n g  g o v e r n m e n t  i n i t i a t i v e s  a n d  f u n d i n g  f o r  i m m u n i z a t i o n  p r o g r a m s  a r e  p r o p e l l i n g  t h e  m a r k e t  f o r w a r d .  M a n y  M E N A  g o v e r n m e n t s  a r e  
c o l l a b o r a t i n g  w i t h  i n t e r n a t i o n a l  h e a l t h  o r g a n i z a t i o n s  t o  e n h a n c e  t h e i r  h e a l t h c a r e  i n f r a s t r u c t u r e  a n d  v a c c i n e  d e l i v e r y  s y s t e m s ,  a i m i n g  t o  a c h i e v e  
h i g h e r  i m m u n i z a t i o n  r a t e s  a c r o s s  t h e i r  p o p u l a t i o n s .  A d d i t i o n a l l y ,  t h e  r e c e n t  g l o b a l  h e a l t h  c r i s e s ,  i n c l u d i n g  t h e  C O V I D - 1 9  p a n d e m i c ,  h a v e  
u n d e r s c o r e d  t h e  c r i t i c a l  r o l e  o f  v a c c i n e s  i n  m a n a g i n g  h e a l t h  e m e r g e n c i e s ,  l e a d i n g  t o  a c c e l e r a t e d  v a c c i n e  d e v e l o p m e n t  a n d  a p p r o v a l  p r o c e s s e s  
i n  t h e  r e g i o n .  T h i s  u r g e n c y  h a s  a l s o  f o s t e r e d  i n n o v a t i o n  a n d  p a r t n e r s h i p s  a m o n g  p h a r m a c e u t i c a l  c o m p a n i e s ,  b i o t e c h n o l o g y  f i r m s ,  a n d  a c a d e m i c  
i n s t i t u t i o n s  w i t h i n  t h e  M E N A  r e g i o n  t o  d e v e l o p  a n d  d i s t r i b u t e  v a c c i n e s  m o r e  e f f i c i e n t l y .  A n o t h e r  t r e n d  i n f l u e n c i n g  t h e  m a r k e t  i s  t h e  g r o w i n g  
a w a r e n e s s  a n d  e d u c a t i o n  a b o u t  t h e  b e n e f i t s  o f  v a c c i n a t i o n ,  w h i c h  i s  g r a d u a l l y  c h a n g i n g  p u b l i c  p e r c e p t i o n s  a n d  i n c r e a s i n g  a c c e p t a n c e  o f  
v a c c i n e s  a c r o s s  d i v e r s e  d e m o g r a p h i c  s e g m e n t s .  F u r t h e r m o r e ,  a d v a n c e m e n t s  i n  b i o t e c h n o l o g y  h a v e  l e d  t o  t h e  d e v e l o p m e n t  o f  m o r e  e f f e c t i v e  
a n d  s a f e r  v a c c i n e s ,  e n h a n c i n g  p u b l i c  c o n f i d e n c e  a n d  d e m a n d .  T h e  i n t r o d u c t i o n  o f  n e w  v a c c i n e  t e c h n o l o g i e s ,  s u c h  a s  m R N A  a n d  v e c t o r - b a s e d  
v a c c i n e s ,  o f f e r s  p o t e n t i a l  f o r  t a c k l i n g  d i s e a s e s  t h a t  w e r e  p r e v i o u s l y  d i f f i c u l t  t o  m a n a g e  t h r o u g h  c o n v e n t i o n a l  v a c c i n a t i o n  a p p r o a c h e s .  A s  t h e  
M E N A  r e g i o n  c o n t i n u e s  t o  f o c u s  o n  i m p r o v i n g  h e a l t h c a r e  o u t c o m e s ,  t h e  v a c c i n e  m a r k e t  i s  e x p e c t e d  t o  e x p a n d ,  d r i v e n  b y  a  c o m b i n a t i o n  o f  
h e a l t h ,  t e c h n o l o g i c a l ,  a n d  g o v e r n m e n t a l  f a c t o r s .
V i e w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / m e n a - v a c c i n e - m a r k e t
Product Type Insights:
• Multivalent Vaccine
• Monovalent Vaccine
 
Treatment Type Insights:
• Preventive Vaccine
• Therapeutic Vaccine
Report 
Segmentation Technology Insights:
• Conjugate Vaccines
• Inact ivated and Subunit  Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• Toxoid Vaccines
• Others
Route of Administration Insights:
• Intramuscular  and Subcutaneous Administrat ion
• Oral Administrat ion
• Others
 
Patient Type Insights:
• Pediatr ic
Report 
• Adult
Segmentation
Indication Insights:
• Bacter ial  Diseases
o Meningococcal Disease
o Pneumococcal  Disease
o Diphther ia/Tetanus/Pertussis (DPT)
o Tuberculosis
o Haemophi lus Infl uenzae (Hib)
o Typhoid
o Others
• Viral  Diseases
o Hepatit is
o Infl uenza
o Human Papi l lomavirus (HPV)
Report o Measles/Mumps/Rubel la (MMR)
o Rotavirus
Segmentation o Herpes Zoster
o Varicel la
o Japanese Encephal i t is
o Rubel la
o Pol io
o Rabies
o Dengue
o Others
Distribution Channel Insights:
• Hospital  Pharmacies
• Retai l  Pharmacies
Report • Insti tut ional  Sales
• Others
Segmentation
End User Insights:
• Hospitals
• Clinics
• Vaccinat ion Centers
• Academic and Research Insti tutes
• Others
Country Insights:
• Saudi Arabia
• Turkey
• Israel
• United Arab Emirates
• Egypt
Report • I ran
• I raq
Segmentation
• Qatar
• Algeria
• Kuwait
• Morocco
• Oman
• Others
How has the MENA vaccine market performed so far 
and how will it perform in the coming years?
What has been the impact of COVID-19 on the 
MENA vaccine market?
Key What is the breakup of the MENA vaccine market on 
the basis of product type?
Questions 
Answered in What is the breakup of the MENA vaccine market on the basis of treatment type?
the Report
What is the breakup of the MENA vaccine market on 
the basis of technology?
What is the breakup of the MENA vaccine market on 
the basis of route of administration?
What is the breakup of the MENA vaccine market on 
the basis of patient type?
What is the breakup of the MENA vaccine market on 
the basis of indication?
What is the breakup of the MENA vaccine market on 
the basis of distribution channel?
Key What is the breakup of the MENA vaccine market on 
the basis of end user?
Questions 
What are the various stages in the value chain of 
Answered in the MENA vaccine market?
the Report
What are the key driving factors and challenges in 
the MENA vaccine?
What is the structure of the MENA vaccine market 
and who are the key players?
What is the degree of competition in the MENA 
vaccine market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4    M E N A  V a c c i n e  M a r k e t  -  I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     M a r k e t  D y n a m i c s
    4 . 3     I n d u s t r y  T r e n d s
    4 . 4     C o m p e t i t i v e  I n t e l l i g e n c e
5    M E N A  V a c c i n e  M a r k e t  L a n d s c a p e
    5 . 1     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
    5 . 2     M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6    M E N A  V a c c i n e  M a r k e t  -  B r e a k u p  b y  P r o d u c t  T y p e
    6 . 1     M u l t i v a l e n t  V a c c i n e
        6 . 1 . 1  O v e r v i e w
        6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 1 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 2     M o n o v a l e n t  V a c c i n e
        6 . 2 . 1  O v e r v i e w
        6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 2 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
       
7    M E N A  V a c c i n e  M a r k e t  -  B r e a k u p  b y  T r e a t m e n t  T y p e
    7 . 1     P r e v e n t i v e  V a c c i n e
        7 . 1 . 1  O v e r v i e w
        7 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 1 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    7 . 2     T h e r a p e u t i c  V a c c i n e
        7 . 2 . 1  O v e r v i e w
        7 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 2 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
8    M E N A  V a c c i n e  M a r k e t  -  B r e a k u p  b y  T e c h n o l o g y
    8 . 1     C o n j u g a t e  V a c c i n e s
Table of         8 . 1 . 1  O v e r v i e w        8 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        8 . 1 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    8 . 2     I n a c t i v a t e d  a n d  S u b u n i t  V a c c i n e s
Contents         8 . 2 . 1  O v e r v i e w        8 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        8 . 2 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    8 . 3     L i v e  A t t e n u a t e d  V a c c i n e s
        8 . 3 . 1  O v e r v i e w
        8 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        8 . 3 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    8 . 4     R e c o m b i n a n t  V a c c i n e s
        8 . 4 . 1  O v e r v i e w
        8 . 4 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        8 . 4 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    8 . 5     T o x o i d  V a c c i n e s
        8 . 5 . 1  O v e r v i e w
        8 . 5 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        8 . 5 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / m e n a -v a cc in e - m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: